- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-5076
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
ASCO 2018: highlights in HER2-positive metastatic breast cancer ; day:11 ; month:10 ; year:2018 ; pages:1-4
Magazine of European Medical Oncology ; (11.10.2018), 1-4
- Creator
-
Bartsch, Rupert
- Contributor
-
Bergen, Elisabeth
SpringerLink (Online service)
- DOI
-
10.1007/s12254-018-0441-x
- URN
-
urn:nbn:de:101:1-2018112004560436464465
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bartsch, Rupert
- Bergen, Elisabeth
- SpringerLink (Online service)
Other Objects (12)
ASCO 2019: highlights in HER2-positive metastatic breast cancer
ASCO 2018 highlights: metastatic breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
ASCO 2021–Gastroesophageal tumor highlights
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer : The best of ASCO 2019
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer
ASCO 2017—highlights of gynecological cancer
ASCO 2016: highlights in breast cancer
2017 ASCO Highlights on Gastointestinal Malignancies
ASCO 2017: highlights in breast cancer
ASCO 2019: highlights in HER2-positive metastatic breast cancer
ASCO 2018 highlights: metastatic breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
ASCO 2021–Gastroesophageal tumor highlights
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer : The best of ASCO 2019
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer
ASCO 2017—highlights of gynecological cancer
ASCO 2016: highlights in breast cancer
2017 ASCO Highlights on Gastointestinal Malignancies
ASCO 2017: highlights in breast cancer
ASCO 2019: highlights in HER2-positive metastatic breast cancer
ASCO 2018 highlights: metastatic breast cancer
How We Treat HER2-Positive Metastatic Breast Cancer
ASCO 2021–Gastroesophageal tumor highlights
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer : The best of ASCO 2019
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer
ASCO 2017—highlights of gynecological cancer
ASCO 2016: highlights in breast cancer
2017 ASCO Highlights on Gastointestinal Malignancies